| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |